Concentrix (CNXC) Expected to Announce Quarterly Earnings on Thursday

Concentrix (NASDAQ:CNXC) is anticipated to announce its Q2 2025 earnings results after the market closes on Thursday, June 26th. Analysts expect the company to announce earnings of $2.76 per share and revenue of $2.38 billion for the quarter.

Concentrix (NASDAQ:CNXC) last announced its quarterly earnings data on Wednesday, March 26th. The company reported $2.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.58 by $0.21. Concentrix had a return on equity of 16.73% and a net margin of 2.81%. The firm had revenue of $2.37 billion for the quarter, compared to analysts’ expectations of $2.37 billion. During the same period last year, the firm earned $2.57 earnings per share. The company’s revenue for the quarter was down 1.3% compared to the same quarter last year.

Concentrix Stock Down 4.4%

Shares of NASDAQ:CNXC opened at $53.16 on Thursday. The stock’s 50-day moving average price is $53.19 and its 200-day moving average price is $49.09. Concentrix has a 12-month low of $36.28 and a 12-month high of $77.00. The stock has a market capitalization of $3.40 billion, a P/E ratio of 13.32, a price-to-earnings-growth ratio of 0.72 and a beta of 0.56. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 1.22.

Concentrix Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, May 6th. Investors of record on Friday, April 25th were paid a $0.3328 dividend. The ex-dividend date of this dividend was Friday, April 25th. This represents a $1.33 annualized dividend and a dividend yield of 2.50%. Concentrix’s payout ratio is presently 33.33%.

Insider Buying and Selling

In other news, CEO Christopher A. Caldwell acquired 1,000 shares of the business’s stock in a transaction on Monday, April 21st. The shares were acquired at an average cost of $46.00 per share, with a total value of $46,000.00. Following the transaction, the chief executive officer now owns 303,362 shares in the company, valued at $13,954,652. The trade was a 0.33% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Cormac J. Twomey sold 500 shares of Concentrix stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $57.06, for a total value of $28,530.00. Following the sale, the executive vice president now directly owns 38,130 shares in the company, valued at approximately $2,175,697.80. The trade was a 1.29% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 30,944 shares of company stock valued at $1,510,158 over the last ninety days. 3.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Concentrix

Large investors have recently made changes to their positions in the business. Geneos Wealth Management Inc. lifted its holdings in shares of Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after purchasing an additional 522 shares during the last quarter. Focus Partners Wealth purchased a new position in shares of Concentrix during the first quarter valued at approximately $781,000. Royal Bank of Canada lifted its holdings in shares of Concentrix by 9.5% during the first quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock valued at $2,643,000 after purchasing an additional 4,133 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Concentrix by 17.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock valued at $8,152,000 after purchasing an additional 21,746 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its holdings in shares of Concentrix by 75.1% during the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock valued at $23,552,000 after purchasing an additional 181,546 shares during the last quarter. 90.34% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Barrington Research cut their target price on Concentrix from $70.00 to $54.00 and set an “outperform” rating on the stock in a research note on Monday, March 24th. Bank of America raised their target price on Concentrix from $59.00 to $65.00 and gave the stock a “neutral” rating in a research note on Monday, June 9th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of $67.25.

About Concentrix

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.